168 related articles for article (PubMed ID: 23290425)
1. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.
Sadetzki S; Bruchim R; Oberman B; Armstrong GN; Lau CC; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut J; Johansen C; Houlston RS; Shete S; Amos CI; Bernstein JL; Olson SH; Jenkins RB; Lachance D; Vick NA; Merrell R; Wrensch M; Davis FG; McCarthy BJ; Lai R; Melin BS; Bondy ML;
Eur J Cancer; 2013 Apr; 49(6):1335-45. PubMed ID: 23290425
[TBL] [Abstract][Full Text] [Related]
2. GLIOGENE an International Consortium to Understand Familial Glioma.
Malmer B; Adatto P; Armstrong G; Barnholtz-Sloan J; Bernstein JL; Claus E; Davis F; Houlston R; Il'yasova D; Jenkins R; Johansen C; Lai R; Lau C; McCarthy B; Nielsen H; Olson SH; Sadetzki S; Shete S; Wiklund F; Wrensch M; Yang P; Bondy M
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1730-4. PubMed ID: 17855690
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H
J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.
Shete S; Lau CC; Houlston RS; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Sadetzki S; Johansen C; Bernstein JL; Olson SH; Jenkins RB; Yang P; Vick NA; Wrensch M; Davis FG; McCarthy BJ; Leung EH; Davis C; Cheng R; Hosking FJ; Armstrong GN; Liu Y; Yu RK; Henriksson R; ; Melin BS; Bondy ML
Cancer Res; 2011 Dec; 71(24):7568-75. PubMed ID: 22037877
[TBL] [Abstract][Full Text] [Related]
5. [Occurrence and molecular pathology of high grade gliomas].
Murnyák B; Csonka T; Hegyi K; Méhes G; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):312-21. PubMed ID: 24358686
[TBL] [Abstract][Full Text] [Related]
6. Familial gliomas: cases in two pairs of brothers.
Osorio JA; Hervey-Jumper SL; Walsh KM; Clarke JL; Butowski NA; Prados MD; Berger MS
J Neurooncol; 2015 Jan; 121(1):135-40. PubMed ID: 25208478
[TBL] [Abstract][Full Text] [Related]
7. Genetic epidemiology of glioma.
Malmer B; Iselius L; Holmberg E; Collins A; Henriksson R; Grönberg H
Br J Cancer; 2001 Feb; 84(3):429-34. PubMed ID: 11161412
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.
Rasmussen BK; Hansen S; Laursen RJ; Kosteljanetz M; Schultz H; Nørgård BM; Guldberg R; Gradel KO
J Neurooncol; 2017 Dec; 135(3):571-579. PubMed ID: 28861666
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
10. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.
Robertson LB; Armstrong GN; Olver BD; Lloyd AL; Shete S; Lau C; Claus EB; Barnholtz-Sloan J; Lai R; Il'yasova D; Schildkraut J; Bernstein JL; Olson SH; Jenkins RB; Yang P; Rynearson AL; Wrensch M; McCoy L; Wienkce JK; McCarthy B; Davis F; Vick NA; Johansen C; Bødtcher H; Sadetzki S; Bruchim RB; Yechezkel GH; Andersson U; Melin BS; Bondy ML; Houlston RS
Fam Cancer; 2010 Sep; 9(3):413-21. PubMed ID: 20455025
[TBL] [Abstract][Full Text] [Related]
11. [Occurrence and molecular pathology of low grade gliomas].
Murnyák B; Csonka T; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
Malmer B; Grönberg H; Andersson U; Jonsson BA; Henriksson R
Acta Oncol; 2001; 40(5):633-7. PubMed ID: 11669337
[TBL] [Abstract][Full Text] [Related]
14. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
[TBL] [Abstract][Full Text] [Related]
15. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
[TBL] [Abstract][Full Text] [Related]
16. Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.
Mohme M; Fritzsche FS; Mende KC; Matschke J; Löbel U; Kammler G; Westphal M; Emami P; Martens T
Neurosurg Focus; 2018 Jun; 44(6):E15. PubMed ID: 29852760
[TBL] [Abstract][Full Text] [Related]
17. Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.
Malmer B; Henriksson R; Grönberg H
Neuroepidemiology; 2002; 21(6):279-86. PubMed ID: 12411730
[TBL] [Abstract][Full Text] [Related]
18. Familial aggregation of glioma: a pooled analysis.
Scheurer ME; Etzel CJ; Liu M; Barnholtz-Sloan J; Wiklund F; Tavelin B; Wrensch MR; Melin BS; Bondy ML;
Am J Epidemiol; 2010 Nov; 172(10):1099-107. PubMed ID: 20858744
[TBL] [Abstract][Full Text] [Related]
19. A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.
Steidl E; Filipski K; Zeiner PS; Wagner M; Fokas E; Forster MT; Ronellenfitsch MW; Divé I; Steinbach JP; Harter PN; Bähr O
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2373-2383. PubMed ID: 33538917
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
